packageAuranofin

auranofin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Auranofin is a gold-based disease-modifying antirheumatic drug used to treat rheumatoid arthritis, and also psoriatic arthritis and pemphigus. It is an approved medicine, though it carries a boxed warning, and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q421230 and the WHO ATC classification; not checked by a person.

name:auranofin
ATC codes:M01CB03
DrugBank:DB00995
PubChem CID:70788951
ChEBI:2922
Wikidata:Q421230
formula:C20H35AuO9PS
molar mass:679.495 g/mol (PubChem CID 70788951)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown